New First-Line Standard in Metastatic Bladder Cancer
‘High bar to beat’ as avelumab maintenance improves median survival by over 7 months
‘High bar to beat’ as avelumab maintenance improves median survival by over 7 months
A large Danish cohort study provides the best evidence to date on which prognostic factors predict relapse in patients with stage I testicular seminoma, researchers…
Opsynvi puts two drugs commonly prescribed for pulmonary arterial hypertension into one tablet
Repurposing malls can increase care access for marginalized communities
Some claim they were offered positions for $150K to $200K, and there’s precedent
Proposed national $35 insulin cap would help some patients, researchers say
Combating vaccine falsehoods and other inaccurate claims protects public health
Crisaborole ointment (Eucrisa) is safe and effective for treating mild-to-moderate atopic dermatitis (AD) in patients older than age 2 — regardless of whether patients were…
Black people, men receive more offers before one is accepted
PFS, adverse events also comparable with the ablative modalities after FOLFIRINOX chemotherapy
Rate of major morbidity was non-inferior in the no-drain group compared with the drain group